Tg(ACTA1-TPM3*M9R)4Hrd
Transgene Detail
|
Symbol: |
Tg(ACTA1-TPM3*M9R)4Hrd |
Name: |
transgene insertion 4, Edna Hardeman |
MGI ID: |
MGI:5444208 |
Synonyms: |
HSA-alphaTmslow(Met9Arg), HSA-alphaTmslow(Met9Arg), HSA-aTmslow(Met9Arg), HSA-aTmslow(Met9Arg), HSA-TPM3*M9R, Tg(TPM3)Met9Arg, TPM3(Met9Arg) |
Transgene: |
Tg(ACTA1-TPM3*M9R)4Hrd Location: unknown
|
Alliance: |
Tg(ACTA1-TPM3*M9R)4Hrd page
|
|
|
Transgene Type: |
|
Transgenic (Dominant negative, Humanized sequence, Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(ACTA1-TPM3*M9R)4Hrd expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
TPM3 (7170) |
|
|
|
|
|
Mutation details: First, the human tropomyosin 3 gene was used to isolate a full-length alphaTmslow cDNA sequence. Next, the sequence was modified by site-directed mutagenesis to have the ATG-to-AGG base pair substitution encoding a methionine-to-arginine substitution at codon 9 (M9R); resulting in the
dominant-negative alphaTmslow(Met9Arg) mutation associated with human nemaline myopathy. The mutant cDNA sequence was placed downstream of a 2.2 kbp human alpha-skeletal actin (ACTA1) promoter sequence, and upstream of a 1022 bp cassette containing the SV40 small t antigen intron and 3' untranslated region. Lines 4, 9 and 14 were generated with high, low and moderate expression levels, respectively.
(J:67596)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:67596 Corbett MA, et al., A mutation in alpha-tropomyosin(slow) affects muscle strength, maturation and hypertrophy in a mouse model for nemaline myopathy. Hum Mol Genet. 2001 Feb 15;10(4):317-28 |
All: |
3 reference(s) |
|